Thought Leadership
LifeSci Talks | From Interview to Endpoint: Understanding the Importance of Patient Listening to Build Better Outcomes
In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with John Reites, Co-Founder and CEO of THREAD research to discuss the importance of patient listening to build better clinical trial endpoints. They delve...
Accelerating Clinical Product Development through Centralized Content Work Streams
As more and more clinical trials are conducted internationally, with a higher level of protocol complexity, and with increased competition to get medical products to market faster globally, the need for efficient and streamlined clinical product development is greater than ever. ...
MedTech Summit EU 2024 | What's Past is Prologue: Evolution (and Future) of AI and Content Automation
Content automation technologies have been developing for 70 years – MDR and IVDR have accelerated this development, as well as adoption across the device industry. And, while product-related applications for artificial intelligence (AI) generate attention-grabbing headlines, the...
Artificial Intelligence in Life Sciences – Latest Developments Presented by Industry Leaders
Join TransPerfect's discussion with industry-experts from Pfizer, Bayer, CodaMetrix, Biogen, BI, Novartis, and Syneos Health about how AI is accelerating changes in the life sciences industry and ways they are leveraging data to support their teams, studies, and products. ...
AI and MT for PV and Safety Office Hours - 6/12/24
Welcome to TransPerfect Life Sciences' AI and MT Ask an Expert Office Hours. In these sessions, we provide an opportunity for our community to submit their pressing questions for our experts to answer live, in the company of your industry peers. If you are looking for some...
Generative AI in Life Sciences Industry: Ethics, Applications, and Transformations
Discover the role of generative artificial intelligence (GenAI) in life sciences, including what is merely a trend vs. what is truly transformative. The speakers will explore pragmatic applications, ethical considerations and the potential future role of generative AI in life...
AI and MT for Regulatory and Clinical Content Office Hours - 5/15/24
Welcome to TransPerfect Life Sciences' AI and MT Ask an Expert Office Hours. In these sessions, we provide an opportunity for our community to submit their pressing questions for our experts to answer live, in the company of your industry peers. If you are looking for some...
AI and MT "Ask an Expert" Office Hours - 4/10/2024
TransPerfect's experts gather to answer questions from global pharma, biotech, and medical device leaders regarding AI and MT use cases, challenges, opportunities, best practices, and more....
LifeSci Talks COA Series | Exploring the Intersection of Clinical Practice and Entrepreneurship: Technological Innovation in Clinical Research
In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Dr Michelle Longmire, CEO of Medable, to discuss her journey from clinical practice to entrepreneurship, driven by a passion for rare disease, and the...
PRO Scheduling Considerations: Assessing Patient & Caregiver Burden in Clinical Trials
In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with Andrew Lloyd, Director at Acaster-Lloyd Consulting, to spotlight the burden of clinical research for patients, and their caregiver/family dynamics. From...
Clinical Content Trends: 2023 Reflections and 2024 Projections
Over the past decade, the pharmaceutical industry has transformed significantly, giving way to breakthrough therapeutics and innovations for improved patient outcomes around the world. With these changes, there’s also been significant developments in the way organizations are...
LifeSci Talks COA Series | Licensing Challenges vs. eCOA Vendor Capabilities
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Stacey Higgins, Associate Director, COA & Digital Implementation Team at AbbVie, to cover the intricacies of clinical trial licensing, contract variations among...
LifeSci Talks COA Series | Decoding Decentralized Trials: Navigating Novel Decentralized Research Challenges and Complexity
DCTs have picked up significantly in previous years, catalyzed by the pandemic and a move to remote research. With this move comes a host of new challenges, including those surrounding technical interoperability, resistance to adopting new technologies, and the need for...
Keeping Patients at the Heart of Clinical Trials
Clinical trial patient recruitment continues to be challenging. Even with shifts to decentralize clinical trials and the addition of new vendors and technology, recruitment still is the primary cause of delays or discontinuation. What could we be missing? In this webinar, we...
LifeSci Talks COA Series | AI-Powered Innovations in Clinical Trials: Optimizing Every Step
Explore how artificial intelligence is rapidly changing the landscape of clinical trials, from discovering new therapies and complex calculations to protocol optimization. Discover how AI can generate study protocols, consent forms, and more, saving time and resources. Join us to...
LifeSci Talks COA Series | The Age of Bring Your Own Device: Considerations for Accessibility in Trial Design
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Dr. Florence Mowlem, VP of Science at ObvioHealth, to discuss maximizing patient accessibility in trial design. This includes implementing accommodations for patients...
LifeSci Talks COA Series | Data Science: The New Frontier
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with Dr. Elizabeth Bacci, Senior Research Scientist at Evidera, to discuss critical aspects of developing meaningful and relevant Digital Health instruments. The...
CCMS: A Good Fit for Pharmaceutical and Clinical Research Organizations?
Kaarin Gordon discusses the choices and challenges for efficient content reuse facing Pharmaceutical and Clinical Research Organizations. What they want is a set of tools and platforms for easy content reuse, automatic propagation of changes from a single source, and content...
LifeSci Talks COA Series | The Future of Capturing Patient Data in Clinical Trials: DCTs, Site Staff Burden, and Regulation Considerations with Paul O'Donohoe
Mark Wade interviews Paul O'Donohoe, Senior Director of Product for eCOA and COA at Medidata. They delve into the challenges and opportunities of adopting decentralized clinical trials (DCTs) and explore topics such as mixed modalities for data capture, patient burden, site...
Transitioning Clinical Trials Under the EU CTR
The transition from Clinical Trial Directive to Clinical Trial Regulation in Europe adds new requirements and complexities to the clinical development landscape. The required transition of all trials concluding January 1st, 2025 brings about several considerations to ensure...